Star Trek as a series usually sticks to its core cast. Throughout most of the shows and their seasons, we get the same ...

Robin Swartz, the Chief Operating Officer and Chief Business Officer of Voyager Therapeutics, Inc. (NASDAQ:VYGR), recently sold 6,950 shares of the company's common stock. The sale comes as the stock ...

At its core, the diamond battery thrives on decay — specifically, the decay of the carbon-14 isotope. Carbon-14 is best known ...

Wedbush reiterated their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report ...

Quark has inked a three-year deal to charter the Voyager solely during the Antarctica cruising season, starting in 2026.

Starforge Systems can build a capable gaming PC, that's for sure. But is notable aesthetic customization enough to set this ...

Voyager Therapeutics said it will assess alternate payloads related to its gene therapeutic program related to a form of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

Thirty years ago today, 'Phage' introduced us to the Vidiians, giving Star Trek one of its best body horror scares wrapped in layers of tragedy.

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

There is no word yet on when the IPO will happen. According to Voyager, it is still working out "the number of shares to be ...

Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today ...

International recommendation adds to the company’s existing credentials in meeting rigorous compliance standards for its ...